$4650 | Single User
$5650 | Multi User
$7150 | Corporate License
$9000 | Enterprise License

Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020

Published by MarketsandMarkets: 04 Apr 2016 | 19932 | In Stock

Introduction

The global virus filtration market is projected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3% between 2015 and 2020. By product, the market includes kits and reagents, filtration systems, other products and services. Based on application segment includes biologicals, medical devices, water purification, and air purification. The biologicals segment is further classified into, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products and stem cell products.

The end user segments included in this report are pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies. The pharmaceutical & biotechnology companies segment is expected to hold the largest share of the virus filtration market in 2015.

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global the virus filtration market in 2015. Asia is expected to register the fastest growth during the forecast period.

The growth of this market is mainly driven by the rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving factors of the virus filtration market. In addition, increasing adoption of single-use technologies is the latest trend observed in the virus filtration market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global virus filtration market and its sub-segments. All percentage shares, splits, and breakdowns for market segments were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been considered, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub segment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all sub segments. It maps market sizes and growth rates for each sub segment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders such as

Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and WuXi PharmaTech (Cayman) Inc. (China).


Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:

• Product Development/Innovation: Product portfolios of the top players in the virus filtration market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market

• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the virus filtration market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various virus filtration across geographies

• Market Diversification: Exhaustive information about new products, recent developments, and investments in the virus filtration market

Table of Contents
for Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020

  • TABLE OF CONTENTS

    1 INTRODUCTION 17

    1.1 OBJECTIVES OF THE STUDY 17

    1.2 MARKET DEFINITION 17

    1.3 MARKET SCOPE 17

    1.3.1 MARKETS COVERED 18

    1.3.2 YEARS CONSIDERED FOR THE STUDY 18

    1.4 CURRENCY 19

    1.5 LIMITATIONS 19

    1.6 STAKEHOLDERS 19

    2 RESEARCH METHODOLOGY 20

    2.1 MARKET SIZE ESTIMATION 21

    2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 24

    2.3 MARKET SHARE ESTIMATION 25

    2.3.1 KEY DATA FROM SECONDARY SOURCES 25

    2.3.2 KEY DATA FROM PRIMARY SOURCES 26

    2.4 ASSUMPTIONS FOR THE STUDY 26

    3 EXECUTIVE SUMMARY 27

    4 PREMIUM INSIGHTS 32

    4.1 VIRUS FILTRATION MARKET OVERVIEW 32

    4.2 LIFE CYCLE ANALYSIS, BY REGION 35

    5 MARKET OVERVIEW 36

    5.1 INTRODUCTION 37

    5.1.1 BY PRODUCT 37

    5.1.2 BY APPLICATION 38

    5.1.3 BY END USER 38

    5.2 MARKET DYNAMICS 39

    5.2.1 DRIVERS 40

    5.2.1.1 Increasing R&D spending 40

    5.2.1.2 Growth in biopharmaceutical industry 41

    5.2.1.3 Increasing government support for the pharmaceutical & biotechnology industry 41

    5.2.2 RESTRAINTS 42

    5.2.2.1 Stringent regulations for validation of filtration products 42

    5.2.2.2 Highly consolidated market 43

    5.2.3 OPPORTUNITIES 43

    5.2.3.1 Asia presents high-growth opportunities 43

    5.2.3.2 Increasing pharmaceutical outsourcing 44

    5.2.4 TREND 45

    5.2.4.1 Rising adoption of single-use technologies 45

    6 VIRUS FILTRATION MARKET, BY PRODUCT 46

    6.1 INTRODUCTION 47

    6.2 KITS AND REAGENTS 49

    6.3 FILTRATION SYSTEMS 50

    6.4 SERVICES 52

    6.5 OTHER PRODUCTS 53

    7 VIRUS FILTRATION MARKET, BY APPLICATION 55

    7.1 INTRODUCTION 56

    7.2 BIOLOGICALS 58

    7.2.1 VACCINES AND THERAPEUTICS 60

    7.2.2 BLOOD AND BLOOD PRODUCTS 62

    7.2.3 CELLULAR AND GENE THERAPY PRODUCTS 63

    7.2.4 TISSUE AND TISSUE PRODUCTS 65

    7.2.5 STEM CELL PRODUCTS 66

    7.3 MEDICAL DEVICES 68

    7.4 WATER PURIFICATION 69

    7.5 AIR PURIFICATION 70

    8 VIRUS FILTRATION MARKET, BY END USER 72

    8.1 INTRODUCTION 73

    8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 75

    8.3 CONTRACT RESEARCH ORGANIZATIONS 77

    8.4 ACADEMIC RESEARCH INSTITUTES 79

    8.5 MEDICAL DEVICE COMPANIES 80

    9 VIRUS FILTRATION MARKET, BY REGION 82

    9.1 INTRODUCTION 83

    9.2 NORTH AMERICA 85

    9.2.1 U.S. 92

    9.2.2 CANADA 96

    9.3 EUROPE 101

    9.4 ASIA 106

    9.4.1 CHINA 112

    9.4.2 JAPAN 116

    9.4.3 INDIA 121

    9.4.4 REST OF ASIA (ROA) 125

    9.5 REST OF THE WORLD (ROW) 130

    10 COMPETITIVE LANDSCAPE 135

    10.1 INTRODUCTION 135

    10.2 STRATEGIC OVERVIEW 135

    10.3 MARKET SHARE ANALYSIS 136

    10.4 COMPETITIVE SITUATION AND TRENDS 137

    10.4.1 NEW PRODUCT LAUNCHES AND UPGRADES 138

    10.4.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 139

    10.4.3 MERGERS & ACQUISITIONS 140

    10.4.4 EXPANSIONS 141

    11 COMPANY PROFILES 142

    (Overview, Financials, Products & Services, Strategy, & Developments)*

    11.1 INTRODUCTION 142

    11.2 MERCK KGAA 143

    11.3 GENERAL ELECTRIC COMPANY 147

    11.4 THERMO FISHER SCIENTIFIC, INC. 151

    11.5 LONZA GROUP LTD. 155

    11.6 PALL CORPORATION 159

    11.7 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 162

    11.8 SIGMA-ALDRICH CORPORATION 165

    11.9 SARTORIUS AG 168

    11.10 ASAHI KASEI MEDICAL CO., LTD. 171

    11.11 WUXI PHARMATECH (CAYMAN) INC. 174

    *Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

    12 APPENDIX 177

    12.1 INSIGHTS OF INDUSTRY EXPERTS 177

    12.2 DISCUSSION GUIDE 178

    12.3 OTHER DEVELOPMENTS 180

    12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 181

    12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 183

    12.6 AVAILABLE CUSTOMIZATIONS 184

    12.7 RELATED REPORTS 185

List Of Tables
in Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020

LIST OF TABLES


TABLE 1 VIRUS FILTRATION MARKET SUMMARY 28

TABLE 2 INCREASING R&D SPENDING: THE PRIMARY GROWTH DRIVER FOR THE VIRUS FILTRATION MARKET 42

TABLE 3 STRINGENT REGULATORY POLICIES FOR VALIDATION OF FILTRATION PRODUCTS TO RESTRICT MARKET GROWTH 43

TABLE 4 ASIA PRESENTS HIGH-GROWTH OPPORTUNITIES IN THE VIRUS FILTRATION MARKET 44

TABLE 5 SINGLE-USE TECHNOLOGIES IS A MAJOR TREND OBSERVED IN THE VIRUS FILTRATION MARKET 45

TABLE 6 VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 48

TABLE 7 VIRUS FILTRATION KITS AND REAGENTS MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 50

TABLE 8 VIRUS FILTRATION SYSTEMS MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 51

TABLE 9 VIRUS FILTRATION SERVICES MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 53

TABLE 10 OTHER VIRUS FILTRATION PRODUCTS MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 54

TABLE 11 VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 57

TABLE 12 VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,

2013–2020 (USD MILLION) 59

TABLE 13 VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY REGION,

2013–2020 (USD MILLION) 60

TABLE 14 VIRUS FILTRATION MARKET SIZE FOR VACCINES AND THERAPEUTICS, BY REGION, 2013–2020 (USD MILLION) 61

TABLE 15 VIRUS FILTRATION MARKET SIZE FOR BLOOD AND BLOOD PRODUCTS, BY REGION, 2013–2020 (USD MILLION) 63

TABLE 16 VIRUS FILTRATION MARKET SIZE FOR CELLULAR AND GENE THERAPY PRODUCTS, BY REGION, 2013–2020 (USD MILLION) 64

TABLE 17 VIRUS FILTRATION MARKET SIZE FOR TISSUE AND TISSUE PRODUCTS, BY REGION, 2013–2020 (USD MILLION) 66

TABLE 18 VIRUS FILTRATION MARKET SIZE FOR STEM CELL PRODUCTS, BY REGION,

2013–2020 (USD MILLION) 67

TABLE 19 VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICES, BY REGION,

2013–2020 (USD MILLION) 68

TABLE 20 VIRUS FILTRATION MARKET SIZE FOR WATER PURIFICATION APPLICATIONS,

BY REGION, 2013–2020 (USD MILLION) 70

TABLE 21 VIRUS FILTRATION MARKET SIZE FOR AIR PURIFICATION APPLICATIONS,

BY REGION, 2013–2020 (USD MILLION) 71

TABLE 22 VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 74

TABLE 23 VIRUS FILTRATION MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2013–2020 (USD MILLION) 76

TABLE 24 VIRUS FILTRATION MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS,

BY REGION, 2013–2020 (USD MILLION) 78

TABLE 25 VIRUS FILTRATION MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES,

BY REGION, 2013–2020 (USD MILLION) 79

TABLE 26 VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY REGION, 2013–2020 (USD MILLION) 81

TABLE 27 VIRUS FILTRATION MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 84

TABLE 28 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 87

TABLE 29 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 88

TABLE 30 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 89

TABLE 31 NORTH AMERICA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 90

TABLE 32 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 91

TABLE 33 U.S.: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 93

TABLE 34 U.S.: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 94

TABLE 35 U.S.: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 95

TABLE 36 U.S.: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 96

TABLE 37 CANADA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 97

TABLE 38 CANADA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 98

TABLE 39 CANADA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 99

TABLE 40 CANADA: VIRUS FILTRATION MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 100

TABLE 41 EUROPE: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 102

TABLE 42 EUROPE: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 103

TABLE 43 EUROPE: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 104

TABLE 44 EUROPE: VIRUS FILTRATION MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 105

TABLE 45 ASIA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 107

TABLE 46 ASIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 108

TABLE 47 ASIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 109

TABLE 48 ASIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,

2013–2020 (USD MILLION) 110

TABLE 49 ASIA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 111

TABLE 50 CHINA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 113

TABLE 51 CHINA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 114

TABLE 52 CHINA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,

2013–2020 (USD MILLION) 115

TABLE 53 CHINA: VIRUS FILTRATION MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 116

TABLE 54 JAPAN: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 117

TABLE 55 JAPAN: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 118

TABLE 56 JAPAN: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,

2013–2020 (USD MILLION) 119

TABLE 57 JAPAN: VIRUS FILTRATION MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 120

TABLE 58 INDIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 122

TABLE 59 INDIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 123

TABLE 60 INDIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,

2013–2020 (USD MILLION) 124

TABLE 61 INDIA: VIRUS FILTRATION MARKET SIZE, BY END USER,

2013–2020 (USD MILLION) 125

TABLE 62 ROA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 126

TABLE 63 ROA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 127

TABLE 64 ROA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,

2013–2020 (USD MILLION) 128

TABLE 65 ROA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 129

TABLE 66 ROW: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 131

TABLE 67 ROW: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,

2013–2020 (USD MILLION) 132

TABLE 68 ROW: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,

2013–2020 (USD MILLION) 133

TABLE 69 ROW: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 134

TABLE 70 MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND MARCH 2016 137

TABLE 71 NEW PRODUCT LAUNCHES AND UPGRADES, 2013–2016 138

TABLE 72 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013–2016 139

TABLE 73 MERGERS & ACQUISITIONS, 2013–2016 140

TABLE 74 EXPANSIONS, 2013–2016 141

List Of Figures, Charts and Diagrams
in Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020

LIST OF FIGURES


FIGURE 1 GLOBAL VIRUS FILTRATION MARKET 18

FIGURE 2 RESEARCH DESIGN 20

FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22

FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 22

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 23

FIGURE 6 DATA TRIANGULATION METHODOLOGY 24

FIGURE 7 VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION) 29

FIGURE 8 VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION) 29

FIGURE 9 BIOLOGICALS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION) 30

FIGURE 10 VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION) 31

FIGURE 11 VIRUS FILTRATION MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION) 31

FIGURE 12 GLOBAL VIRUS FILTRATION MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD 32

FIGURE 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE THE VIRUS FILTRATION MARKET IN 2015 33

FIGURE 14 ASIA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 34

FIGURE 15 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES 35

FIGURE 16 VIRUS FILTRATION MARKET SEGMENTATION: BY PRODUCT 37

FIGURE 17 VIRUS FILTRATION MARKET SEGMENTATION: BY APPLICATION 38

FIGURE 18 VIRUS FILTRATION MARKET SEGMENTATION: BY END USER 38

FIGURE 19 INCREASING R&D SPENDING WILL DRIVE THE VIRUS FILTRATION MARKET DURING THE FORECAST PERIOD 39

FIGURE 20 GLOBAL PHARMACEUTICAL R&D SPENDING (2001–2011) 40

FIGURE 21 VIRUS FILTRATION MARKET SEGMENTATION, BY PRODUCT 47

FIGURE 22 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN 2015 48

FIGURE 23 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION KITS AND REAGENTS MARKET IN 2015 49

FIGURE 24 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION SYSTEMS MARKET IN 2015 51

FIGURE 25 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF VIRUS FILTRATION SERVICES MARKET IN 2015 52

FIGURE 26 NORTH AMERICA TO DOMINATE THE OTHER VIRUS FILTRATION PRODUCTS MARKET IN 2015 53

FIGURE 27 VIRUS FILTRATION MARKET SEGMENTATION, BY APPLICATION 56

FIGURE 28 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET

IN 2015 57

FIGURE 29 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015 58

FIGURE 30 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015 59

FIGURE 31 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR VACCINES AND THERAPEUTICS IN 2015 61

FIGURE 32 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR BLOOD AND BLOOD PRODUCTS IN 2015 62

FIGURE 33 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CELLULAR AND GENE THERAPY PRODUCTS IN 2015 64

FIGURE 34 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR TISSUE AND TISSUE PRODUCTS IN 2015 65

FIGURE 35 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR STEM CELL PRODUCTS IN 2015 67

FIGURE 36 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICES IN 2015 68

FIGURE 37 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR WATER PURIFICATION APPLICATIONS IN 2015 69

FIGURE 38 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR AIR PURIFICATION APPLICATIONS IN 2015 70

FIGURE 39 VIRUS FILTRATION MARKET SEGMENTATION, BY END USER 73

FIGURE 40 VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 (USD MILLION) 74

FIGURE 41 PATENTS FILED: GLOBAL DISTRIBUTION IN 2012 75

FIGURE 42 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN 2015 76

FIGURE 43 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BETWEEN 2015 AND 2020 78

FIGURE 44 ASIA TO WITNESS HIGHEST GROWTH IN THE VIRUS FILTRATION MARKET FOR ACADEMIC RESEARCH INSTITUTES 79

FIGURE 45 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICE COMPANIES BETWEEN 2015 AND 2020 80

FIGURE 46 VIRUS FILTRATION MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2015-2020 83

FIGURE 47 VIRUS FILTRATION MARKET IN ASIA TO GROW AT THE HIGHEST RATE (2015 TO 2020) 84

FIGURE 48 NORTH AMERICA: VIRUS FILTRATION MARKET SNAPSHOT 86

FIGURE 49 U.S. TO DOMINATE THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015 87

FIGURE 50 KITS & REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015 88

FIGURE 51 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015 89

FIGURE 52 VACCINES & THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE NORTH AMERICAN BIOLOGICALS MARKET IN 2015 90

FIGURE 53 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN NORTH AMERICA 91

FIGURE 54 KITS & REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE U.S. VIRUS FILTRATION MARKET IN 2015 92

FIGURE 55 BIOLOGICALS APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. VIRUS FILTRATION MARKET IN 2015 93

FIGURE 56 VACCINES & THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE U.S. VIRUS FILTRATION BIOLOGICALS MARKET IN 2015 94

FIGURE 57 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN THE U.S. 95

FIGURE 58 KITS & REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN CANADA IN 2015 97

FIGURE 59 BIOLOGICALS TO ACCOUNT FOR THE LARGEST OF THE VIRUS FILTRATION APPLICATIONS MARKET IN CANADA IN 2015 98

FIGURE 60 KITS & REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT OF VIRUS FILTRATION BIOLOGICALS MARKET IN CANADA 99

FIGURE 61 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CANADA 100

FIGURE 62 KITS & REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN VIRUS FILTRATION MARKET IN 2015 101

FIGURE 63 BIOLOGICALS TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATIONS MARKET IN EUROPE IN 2015 102

FIGURE 64 VACCINES AND THERAPEUTICS TO FORM THE LARGEST SEGMENT IN THE VIRUS FILTRATION BIOLOGICALS MARKET IN EUROPE 103

FIGURE 65 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN EUROPE 104

FIGURE 66 ASIAN VIRUS FILTRATION MARKET SNAPSHOT 106

FIGURE 67 CHINA ESTIMATED TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET IN 2015 107

FIGURE 68 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE ASIAN MARKET IN 2015 108

FIGURE 69 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATION MARKET IN ASIA IN 2015 109

FIGURE 70 VACCINES AND THERAPEUTICS TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015 110

FIGURE 71 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN ASIA 111

FIGURE 72 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN CHINA IN 2015 112

FIGURE 73 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET IN CHINA IN 2015 113

FIGURE 74 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN CHINA IN 2015 114

FIGURE 75 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CHINA 115

FIGURE 76 KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN JAPAN IN 2015 117

FIGURE 77 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN JAPAN IN 2015 118

FIGURE 78 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN JAPAN IN 2015 119

FIGURE 79 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN JAPAN 120

FIGURE 80 KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN INDIA IN 2015 121

FIGURE 81 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN INDIA IN 2015 122

FIGURE 82 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN INDIA IN 2015 123

FIGURE 83 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN INDIA 124

FIGURE 84 KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN ROA IN 2015 126

FIGURE 85 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN ROA IN 2015 127

FIGURE 86 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROA IN 2015 128

FIGURE 87 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN ROA 129

FIGURE 88 KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ROW VIRUS FILTRATION MARKET IN 2015 130

FIGURE 89 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION APPLICATION MARKET IN 2015 131

FIGURE 90 VACCINES AND THERAPEUTICS ESTIMATED TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROW IN 2015 132

FIGURE 91 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION END-USER MARKET 133

FIGURE 92 NEW PRODUCT LAUNCHES AND UPGRADES WAS THE KEY STRATEGY ADOPTED

BY PLAYERS IN THE VIRUS FILTRATION MARKET 135

FIGURE 93 VIRUS FILTRATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 136

FIGURE 94 FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS 142

FIGURE 95 COMPANY SNAPSHOT: MERCK & CO., INC. 143

FIGURE 96 COMPANY SNAPSHOT: GENERAL ELECTRIC COMPANY 147

FIGURE 97 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC. 151

FIGURE 98 COMPANY SNAPSHOT: LONZA GROUP LTD. 155

FIGURE 99 COMPANY SNAPSHOT: PALL CORPORATION 159

FIGURE 100 COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 162

FIGURE 101 COMPANY SNAPSHOT: SIGMA-ALDRICH CORPORATION 165

FIGURE 102 COMPANY SNAPSHOT: SARTORIUS AG 168

FIGURE 103 COMPANY SNAPSHOT: ASAHI KASEI MEDICAL CO., LTD. 171

FIGURE 104 COMPANY SNAPSHOT: WUXI PHARMATECH (CAYMAN) INC. 174

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

19932 | BT 4204

Number of Pages

186

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Human Papilloma Virus Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Global Respiratory Syncytial Virus Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis to 2024
Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis to 2024SummaryChronic he...
15 Jan 2016 by Global Data USD $4,995 More Info
Hepatitis B Virus (HBV) Therapeutics - Japan Drug Forecast and Market Analysis to 2024
Hepatitis B Virus (HBV) Therapeutics - Japan Drug Forecast and Market Analysis to 2024SummaryChronic...
15 Jan 2016 by Global Data USD $4,995 More Info
Hepatitis B Virus (HBV) Therapeutics - China Drug Forecast and Market Analysis to 2024
Hepatitis B Virus (HBV) Therapeutics - China Drug Forecast and Market Analysis to 2024SummaryChronic...
15 Jan 2016 by Global Data USD $4,995 More Info
Hepatitis B Virus (HBV) Therapeutics - 5EU Drug Forecast and Market Analysis to 2024
Hepatitis B Virus (HBV) Therapeutics - 5EU Drug Forecast and Market Analysis to 2024SummaryChronic h...
15 Jan 2016 by Global Data USD $6,995 More Info
Hepatitis B Virus (HBV) Therapeutics - Current and Future Players
Hepatitis B Virus (HBV) Therapeutics - Current and Future PlayersSummaryGlobalData has released its ...
15 Jan 2016 by Global Data USD $2,995 More Info
OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) - Opportunity Analysis and Forecasts to 2024
OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) - Opportunity Analysis and Forecasts to 2024S...
01 Jan 2016 by Global Data USD $9,495 More Info
PharmaPoint: Hepatitis B Virus (HBV) Therapeutics - Global Drug Forecast and Market Analysis to 2024
PharmaPoint: Hepatitis B Virus (HBV) Therapeutics - Global Drug Forecast and Market Analysis to 2024...
01 Jan 2016 by Global Data USD $10,995 More Info
EpiCast Report: Respiratory Syncytial Virus Infection - Epidemiology Forecast to 2024
EpiCast Report: Respiratory Syncytial Virus Infection - Epidemiology Forecast to 2024SummaryRSV is a...
23 Dec 2015 by Global Data USD $3,995 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data